Cytonics Stock

cytonics.comHealthcareFounded: 2006

Cytonics is a biotechnology research and development company that specializes in developing diagnostics and therapeutics for osteoarthritis. Their flagship product was the Fibronectin-Aggrecan Complex Test, which can detect cartilage damage due to osteoarthritis from samples of patients’ joint fluid. The company was founded by Gaetano Scuderi MD in 2006 and is headquartered in Jupiter, FL.

Register for Details

For more details on financing and valuation for Cytonics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Cytonics.

Register Today

Cytonics investors also invested in these private companies

DePuy Synthes
National Institutes of Health

Team

Management Team

Antonio Carvalho
Co-Chief Executive Officer, Chief Financial Officer & Board Member
Joey Bose
Co-Chief Executive Officer, President & Board Member
Lewis Hanna Ph.D
Chief Scientific Officer
Gaetano Scuderi MD
Founder & Chairman of the Board

Board Members

Gordon Ramseier
Board Member
Phil LoGrasso Ph.D
Board Member
Tracey Goeken MD
Board Member

Other companies like Cytonics in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$4.26B
Sector